AUSTIN, Texas, Nov 29, 2005 (UPI via COMTEX) -- A new anthrax antibody engineered by Texas scientists might result in an anthrax cure.
The high-affinity antibody, an anthrax antitoxin, reportedly protects and defends against inhalation anthrax without the use of antibiotics and other more expensive antibodies.
The engineered antibody successfully eliminated both anthrax bacteria and its deadly toxins in animal tests, researchers said. If future tests concur, they said it might be the first successful treatment for late-stage anthrax infection, even for an anthrax strain that has been designed to resist antibiotics.
The study was a collaborative effort between Brent Iverson and George Georgiou at The University of Texas-Austin and a research team led by Jean Patterson at the Southwest Foundation for Biomedical Research in San Antonio.
The research is reported in the December issue of the journal Infection and Immunity.
URL: www.upi.com